Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome.

Sattigeri JA, Sethi S, Davis JA, Ahmed S, Rayasam GV, Jadhav BG, Chilla SM, Datta D, Gadhave A, Tulasi VK, Jain T, Voleti S, Benjamin B, Udupa S, Jain G, Singh Y, Srinivas K, Bansal VS, Ray A, Bhatnagar PK, Cliffe IA.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2313-2318. doi: 10.1016/j.bmcl.2017.04.036. Epub 2017 Apr 13.

PMID:
28442252
2.

Genes involved in pancreatic islet cell rejuvenation.

Bansal VS, Raja CP, Venkataraman K, Vijayalakshmi MA.

Indian J Med Res. 2013 Apr;137(4):695-703. Review.

3.

Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model.

Davis JA, Kumar PS, Singh S, Surender A, Roy S, Khanna V, Sethi S, Pal C, Sharma L, Benjamin B, Mittra S, Sattigeri J, Bansal VS.

Indian J Pharmacol. 2012 Nov-Dec;44(6):759-64. doi: 10.4103/0253-7613.103298.

4.

Antihyperglycemic effect of Annona squamosa hexane extract in type 2 diabetes animal model: PTP1B inhibition, a possible mechanism of action?

Davis JA, Sharma S, Mittra S, Sujatha S, Kanaujia A, Shukla G, Katiyar C, Lakshmi BS, Bansal VS, Bhatnagar PK.

Indian J Pharmacol. 2012 May;44(3):326-32. doi: 10.4103/0253-7613.96304.

5.

RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.

Singh S, Roy S, Sethi S, Benjamin B, Sundaram S, Khanna V, Kandalkar SR, Pal C, Kant R, Patra AK, Rayasam G, Mittra S, Saini KS, Paliwal J, Chugh A, Ahmed S, Sattigeri J, Cliff I, Ray A, Bansal VS, Bhatnagar PK, Davis JA.

Eur J Pharmacol. 2011 Feb 10;652(1-3):157-63. doi: 10.1016/j.ejphar.2010.06.001. Epub 2010 Jun 9. Erratum in: Eur J Pharmacol. 2011 Mar 25;655(1-3):121. multiple author names added.

PMID:
20540938
6.

Discovery of conformationally rigid 3-azabicyclo[3.1.0]hexane-derived dipeptidyl peptidase-IV inhibitors.

Sattigeri JA, Andappan MM, Kishore K, Thangathirupathy S, Sundaram S, Singh S, Sharma S, Davis JA, Chugh A, Bansal VS.

Bioorg Med Chem Lett. 2008 Jul 15;18(14):4087-91. doi: 10.1016/j.bmcl.2008.05.101. Epub 2008 Jul 2.

PMID:
18602260
7.

From a glucocentric to a lipocentric approach towards metabolic syndrome.

Mittra S, Bansal VS, Bhatnagar PK.

Drug Discov Today. 2008 Mar;13(5-6):211-8. doi: 10.1016/j.drudis.2008.01.006. Epub 2008 Mar 7. Review.

PMID:
18342796
8.

Topiramate and type 2 diabetes: an old wine in a new bottle.

Khanna V, Arumugam S, Roy S, Mittra S, Bansal VS.

Expert Opin Ther Targets. 2008 Jan;12(1):81-90. Review.

PMID:
18076372
9.

Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice.

Roy S, Khanna V, Mittra S, Dhar A, Singh S, Mahajan DC, Priyadarsiny P, Davis JA, Sattigeri J, Saini KS, Bansal VS.

Life Sci. 2007 Jun 13;81(1):72-9. Epub 2007 May 1.

PMID:
17532347
10.

Fatty acid receptors as new therapeutic targets for diabetes.

Rayasam GV, Tulasi VK, Davis JA, Bansal VS.

Expert Opin Ther Targets. 2007 May;11(5):661-71. Review.

PMID:
17465724
11.

Increase in weight induced by muraglitazar, a dual PPARalpha/gamma agonist, in db/db mice: adipogenesis/or oedema?

Mittra S, Sangle G, Tandon R, Sharma S, Roy S, Khanna V, Gupta A, Sattigeri J, Sharma L, Priyadarsiny P, Khattar SK, Bora RS, Saini KS, Bansal VS.

Br J Pharmacol. 2007 Feb;150(4):480-7. Epub 2007 Jan 8.

12.

Small molecule antagonists of complement receptor type 3 block adhesion and adhesion-dependent oxidative burst in human polymorphonuclear leukocytes.

Bansal VS, Vaidya S, Somers EP, Kanuga M, Shevell D, Weikel R, Detmers PA.

J Pharmacol Exp Ther. 2003 Mar;304(3):1016-24.

PMID:
12604677
14.

Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.

Vaidya S, Bostedor R, Kurtz MM, Bergstrom JD, Bansal VS.

Arch Biochem Biophys. 1998 Jul 1;355(1):84-92.

PMID:
9647670
15.

Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol.

Bostedor RG, Karkas JD, Arison BH, Bansal VS, Vaidya S, Germershausen JI, Kurtz MM, Bergstrom JD.

J Biol Chem. 1997 Apr 4;272(14):9197-203.

16.

Characterization of two distinct allyl pyrophosphatase activities from rat liver microsomes.

Bansal VS, Vaidya S.

Arch Biochem Biophys. 1994 Dec;315(2):393-9.

PMID:
7986083
17.

Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.

Bergstrom JD, Kurtz MM, Rew DJ, Amend AM, Karkas JD, Bostedor RG, Bansal VS, Dufresne C, VanMiddlesworth FL, Hensens OD, et al.

Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):80-4.

18.
19.

The phosphatidylinositol pathway of platelets and vascular cells.

Majerus PW, Bansal VS, Lips DL, Ross TA, Mitchell CA, Caldwell KK, Cunningham TW.

Ann N Y Acad Sci. 1991;614:44-50. Review. No abstract available.

PMID:
2024892
20.

Pathway for the formation of D-3 phosphate containing inositol phospholipids in intact human platelets.

Cunningham TW, Lips DL, Bansal VS, Caldwell KK, Mitchell CA, Majerus PW.

J Biol Chem. 1990 Dec 15;265(35):21676-83.

21.

Recent insights in phosphatidylinositol signaling.

Majerus PW, Ross TS, Cunningham TW, Caldwell KK, Jefferson AB, Bansal VS.

Cell. 1990 Nov 2;63(3):459-65. Review.

PMID:
2225061
22.

The isolation and characterization of inositol polyphosphate 4-phosphatase.

Bansal VS, Caldwell KK, Majerus PW.

J Biol Chem. 1990 Jan 25;265(3):1806-11.

23.

Phosphatidylinositol-derived precursors and signals.

Bansal VS, Majerus PW.

Annu Rev Cell Biol. 1990;6:41-67. Review. No abstract available.

PMID:
2275819
24.

Dexamethasone-induced reduction of phospholipase D activity in the rat. Possible role of lipocortin.

Kobayashi M, Bansal VS, Singh I, Kanfer JN.

FEBS Lett. 1988 Aug 29;236(2):380-2.

25.

Inositol phosphates: synthesis and degradation.

Majerus PW, Connolly TM, Bansal VS, Inhorn RC, Ross TS, Lips DL.

J Biol Chem. 1988 Mar 5;263(7):3051-4. Review. No abstract available.

26.

The metabolism of inositol 1,3,4-trisphosphate to inositol 1,3-bisphosphate.

Bansal VS, Inhorn RC, Majerus PW.

J Biol Chem. 1987 Jul 15;262(20):9444-7.

27.

Pathway for inositol 1,3,4-trisphosphate and 1,4-bisphosphate metabolism.

Inhorn RC, Bansal VS, Majerus PW.

Proc Natl Acad Sci U S A. 1987 Apr;84(8):2170-4.

28.

The metabolism of tris- and tetraphosphates of inositol by 5-phosphomonoesterase and 3-kinase enzymes.

Connolly TM, Bansal VS, Bross TE, Irvine RF, Majerus PW.

J Biol Chem. 1987 Feb 15;262(5):2146-9.

29.

The metabolism of phosphoinositide-derived messenger molecules.

Majerus PW, Connolly TM, Deckmyn H, Ross TS, Bross TE, Ishii H, Bansal VS, Wilson DB.

Science. 1986 Dec 19;234(4783):1519-26. Review.

PMID:
3024320
30.

The phospholipid-N-methyltransferase of rat brain microsomes.

Bansal VS, Kanfer JN.

Biochim Biophys Acta. 1985 Aug 22;836(1):73-9.

PMID:
4027261
31.

Chemical methylation of phosphatidylethanolamine by S-adenosylmethionine.

Bansal VS, Kanfer JN.

Biochem Biophys Res Commun. 1985 Apr 16;128(1):411-6.

PMID:
3985978
32.
33.
34.

Effect of carbon sources on the polar lipid fatty acids of Microsporum gypseum grown at different temperatures.

Jindal HK, Bansal VS, Kasinathan C, Larroya S, Khuller GK.

Experientia. 1983 Feb 15;39(2):151-3. No abstract available.

PMID:
6832290
35.

In vivo studies on phospholipid biosynthesis in Microsporum gypseum.

Bansal VS, Chopra A, Kasinathan C, Khuller GK.

Indian J Med Res. 1982 Dec;76:832-6. No abstract available.

PMID:
6820356
36.

Phospholipid and fatty acid composition of Microsporum cookei: effect of exogenous unsaturated fatty acids.

Bansal VS, Khuller GK.

Sabouraudia. 1981 Dec;19(4):307-10. No abstract available.

PMID:
7323910
37.

Effect of glycerol substitution & choline/ethanolamine supplementation phospholipid & fatty acid composition of Microsporum gypseum.

Khuller GK, Kasinathan C, Bansal VS, Chopra A.

Indian J Exp Biol. 1981 Nov;19(11):1054-7. No abstract available.

PMID:
7338362
38.

Biosynthesis of neutral lipids in Microsporum gypseum.

Bansal VS, Chopra A, Kasinathan C, Khuller GK.

Sabouraudia. 1981 Sep;19(3):223-6. No abstract available.

PMID:
7292209
39.

Temperature-induced alterations in phospholipid & fatty acid composition of Microsporum species.

Bansal VS, Khuller GK.

Indian J Biochem Biophys. 1981 Feb;18(1):74-5. No abstract available.

PMID:
7275155
40.

Lipids of dermatophytes.

Khuller GK, Chopra A, Bansal VS, Masih R.

Lipids. 1981 Jan;16(1):20-2.

PMID:
7219077
41.

Characterization of phospholipase A in Streptomyces griseus.

Verma JN, Bansal VS, Khuller GK, Subrahmanyam D.

Indian J Med Res. 1980 Oct;72:487-91. No abstract available.

PMID:
6785216
42.

Characterization of Ca2+-ATPase activity in Streptomyces griseus.

Bansal VS, Verma JN, Mahmood A, Khuller GK.

J Gen Microbiol. 1979 Jun;112(2):393-5.

PMID:
158068
43.

Changes in the phospholipid composition of Microsporum gypesum during growth.

Khuller GK, Verma JN, Bansal VS, Talwar P.

Indian J Med Res. 1978 Aug;68:234-6. No abstract available.

PMID:
721197
44.

Studies on serum calcium, phosphorus & blood phosphatases in growing cross-bred dairy calves.

Bansal VS, Prasad A, Pandey RS.

Indian J Exp Biol. 1977 Oct;15(10):935-6. No abstract available.

PMID:
606659

Supplemental Content

Loading ...
Support Center